dc.contributor.author | BILGIN, Melek | |
dc.contributor.author | Hokelek, MURAT | |
dc.contributor.author | Yildirim, Tuba | |
dc.date.accessioned | 2021-03-03T07:33:41Z | |
dc.date.available | 2021-03-03T07:33:41Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | BILGIN M., Yildirim T., Hokelek M., "In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii", BALKAN MEDICAL JOURNAL, cilt.30, sa.1, ss.19-22, 2013 | |
dc.identifier.issn | 2146-3123 | |
dc.identifier.other | av_129e20e0-2276-4768-bdaa-faea0f5b02d7 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/17962 | |
dc.identifier.uri | https://doi.org/10.5152/balkanmedj.2012.098 | |
dc.description.abstract | Objective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii | |
dc.type | Makale | |
dc.relation.journal | BALKAN MEDICAL JOURNAL | |
dc.contributor.department | Samsun Training & Research Hospital , , | |
dc.identifier.volume | 30 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 19 | |
dc.identifier.endpage | 22 | |
dc.contributor.firstauthorID | 51760 | |